Skip to main content
. 2013 Sep 10;10(9):e1001511. doi: 10.1371/journal.pmed.1001511

Table 1. Enrollment characteristics of study participants.

Characteristics Partners PrEP Participants Adherence Substudy Sites
Total TDF Arm FTC/TDF Arm Placebo Arm Participant Not Enrolleda
n (%) or Median (IQR)
Individual characteristics n = 4,747 n = 1147 n = 359 n = 386 n = 402 n = 597
Male gender 2,962 (62%) 608 (53%) 196 (55%) 203 (53%) 209 (52%) 349 (58%)
Years of education 7 (4–10) 6 (3–7) 6 (3–8) 6 (3–8) 6 (3–8) 6 (3–9)
Age in years 33 (28–40) 34 (30–40) 34 (29–40) 35 (30–40) 34 (30–40) 34 (28–40)
Placebo 1,584 (33%) 402 (35%) n/a n/a n/a 183 (31%)
Entry into the adherence study
Concurrent with trial enrollment n/a 290 (25%) 97 (27%) 100 (26%) 93 (23%) n/a
Months 1–6 n/a 182 (16%) 62 (17%) 56 (15%) 64 (16%) n/a
Months 7–12 n/a 202 (18%) 61 (17%) 68 (18%) 73 (18%) n/a
After month 12 n/a 473 (41%) 139 (39%) 162 (42%) 172 (43%) n/a
Partnership characteristics
Married 4,635 (98%) 1,135 (99%) 353 (98%) 383 (99%) 399 (99%) 581 (97%)
Living together 4,650 (98%) 1,129 (98%) 353 (98%) 382 (99%) 394 (98%) 585 (98%)
Number of years living together 7.0 (3.0–14.0) 8.5 (3.7–15.3) 8.2 (3.6–15.0) 8.0 (3.7–15.3) 9.0 (3.8–15.9) 7.1 (3.0–14.2)
Number of children in the partnership 2 (1–4) 2 (1–4) 2 (1–4) 2 (1–4) 2 (1–4) 2 (1–4)
Polygamous marriage 974 (21%) 282 (25%) 82 (23%) 104 (27%) 96 (24%) 158 (27%)
Age difference between partners 1 (−4 to 6) 0 (−5 to 5) 1 (−6 to 5) 0 (−6 to 5) 0 (−5 to 5) 0 (−6 to 6)
Unprotected sex in prior month 1267 (28%) 321 (29%) 107 (30%) 111 (30%) 103 (26%) 142 (25%)
HIV-infected partner CD4 count (cells/mm3) 495 (375–662) 491 (368–667) 464 (348–626) 503 (380–682) 504 (372–687) 477 (355–645)
HIV-infected partner viral load (log copies/ml) 3.9 (3.2–4.5) 4.0 (3.3–4.6) 4.1 (3.4–4.6) 3.9 (3.2–4.5) 4.0 (3.4–4.6) 4.0 (3.3–4.6)

Complete data were available on all variables (n = 1,147) except for questions regarding unprotected sex in the prior month (missing in 3%), polygamy (<1%), and viral load (1%).

a

From the three sites from which the adherence substudy recruited.

n/a, not applicable.